Kronisk lymfatisk leukæmi

Translated title of the contribution: Chronic lymphocytic leukaemia


Chronic lymphocytic leukaemia (CLL) is the most common leukaemia in the world with approximately 450 new cases yearly in Denmark. The disease is highly heterogeneous, and half of the patients will never require treatment. The standard treatment is chemoimmunotherapy, but highly effective targeted therapies are approved for patients with high-risk disease or relapse as summarised in this review. The Danish CLL guidelines are continuously updated based on results from ongoing clinical trials and international guidelines.

Translated title of the contributionChronic lymphocytic leukaemia
Original languageDanish
JournalUgeskrift for Laeger
Issue number42
Pages (from-to)V03210259
Publication statusPublished - 18 Oct 2021


Dive into the research topics of 'Chronic lymphocytic leukaemia'. Together they form a unique fingerprint.

Cite this